Portal de Murcia

www.portaldemurcia.com

• Home
• Business
• Hotels
• Restaurants
• News
• Advertisement

The BIO-HPC Group of the UCAM, thanks to the funding obtained in the 'Proof of Concept' call of the Séneca Foundation (20524 / PDC / 18), will be present at the XIII Annual International Partnering Conference 'Bio Europe Spring'.

It is expected that some 1,500 companies will pass from March 25 to 27 at the Exhibition and Congress Center `Messe Wien 'in Vienna (Austria), where the UCAM researchers, Horacio Pérez Sánchez and José Pedro Cerón Carrasco, will be in charge of present to the attendees the novelties recently implemented in the technology developed by the group itself in the field of computational chemistry for the discovery of new drugs.

The "Blind Docking" technique developed by the BIO-HPC group of the UCAM will solve some of the common problems in drug discovery, related to privacy when working in a "cloud" tool.

Currently, UCAM researchers are working on the installation of this tool in local computing devices that will show these days to the private sector so that they can work on them, being able to completely format the system once the calculations are finished.

With the new version of the system, in addition, a customized premium version can be ordered to adapt it to the specific needs of the different companies in the pharmaceutical sector.

Source: UCAM